Article Per Year (5 Year)
p-Index From 2020 - 2025
0.751
P-Index
This Author published in this journals
All Journal Indonesian Journal of Pharmaceutical Science and Technology Abdi Geomedisains Journal of Pharmaceutical and Sciences. Usadha Journal of Pharmacy
Fadhilah, Arini
Unknown Affiliation
Agriculture, Biological Sciences & Forestry Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Computer Science & IT Dentistry Earth & Planetary Sciences Environmental Science Immunology & microbiology Materials Science & Nanotechnology Medicine & Pharmacology Nursing Public Health

Published : 4 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search
Journal : Indonesian Journal of Pharmaceutical Science and Technology

 1 
Antidiabetic activity of matoa leaves (Pometia pinnata J.R.Forst & G. Forst) extract on hyperglycaemic alloxan-induced rats Wahyuni, Arifah Sri; Muflihah, Cita Hanif; Fadhilah, Arini; Oksaputra, Amar Khoiri; Ningrum, Nur Faizah Setya; Bakhtiar, Muhammad
Indonesian Journal of Pharmaceutical Science and Technology Vol 10, No 3 (2023)
Publisher : Indonesian Journal of Pharmaceutical Science and Technology

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24198/ijpst.v10i3.33711

Abstract

Matoa (Pometia pinnata J.R.Forst & G. Forst) leaves contain polyphenols and flavonoids which areprospective for the development of the new antidiabetic agent. This research aimed to explore thepotency of matoa leaves in reducing blood glucose level and increasing plasma insulin concentrationin alloxan-induced rats. The experimental study was done in 6 treatment groups: the aquadest (normal),alloxan (Alx) 150 mg/kgBW (negative control), glibenclamide (Gli) 5 mg/kgBW (positive control),and matoa leaves extract (MLE) at the doses of 50, 100, and 200 mg/kgBW. The treatment wasadministered for 14 days orally post-induction of alloxan and fasting blood glucose (FBG) reached>200 mg/dL. Blood glucose levels were established by the GOD-PAP (Diasys) method while plasmainsulin was measured using Rat insulin ELISA kit. Hematoxyline-eosin (HE) staining on tissues wasperformed to observe the population of pancreatic beta cells. The results showed that the MLE extractat a dose of 200 mg/kgBW could decrease the FBG level to 135.25±21.14 mg/dL and increase theplasma insulin level up to 0.14%. Pancreas histopathology indicated that the number of damaged cellswere lower than negative control. In conclusion, our results affirm the promising potential of MLE asa candidate of the novel antidiabetic agent.
Co-Authors Arifah Sri Wahyuni Astuti , Dina Puji Bakhtiar, Muhammad Cita Hanif Muflihah Fauzi Ahmad Muda Haryoto Husada, Dani Fahri Ningrum, Nur Faizah Setya Oksaputra, Amar Khoiri